12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Lane Labs preclinical data

In a study of 24 mice with implanted tumors, oral treatment with 1 g/day of BeneFin reduced tumor growth...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >